CompletedNot Applicable

Rhinological Outcomes in Endonasal Pituitary Surgery

United States235 participantsStarted 2011-10-01

Plain-language summary

This is a prospective, multi-center observational study designed to address patient-reported nasal outcomes in adults undergoing endoscopic and microscopic surgical removal of pituitary tumors. The primary objective of this study is to determine the difference in nasal outcomes by using the Anterior Skull Base (ASK) Nasal survey between patients treated with endoscopic surgical technique and those treated with microscopic surgical technique. Patients will be given the ASK Nasal survey to assess their nasal functioning and overall health before their surgery, and at post-operative visits 1-2 weeks, 3 months, and 6 months.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pituitary tumor patients treated by transsphenoidal route * Adults (age 18-80 years) * Direct endonasal or endoscopic approach * Non-functioning adenoma, Cushing's disease, acromegaly Exclusion Criteria: * Patients treated by expanded endonasal approaches (transtubercular approach) * Sublabial approach

What they're measuring

ASK Nasal symptom severity scores and SF-8 scores

Timeframe: 3 months

Validation of ASK Nasal survey tool

Timeframe: 3 months

Trial details

NCT IDNCT01504399

SponsorSt. Joseph's Hospital and Medical Center, Phoenix

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-06-01

View on ClinicalTrials.gov More Pituitary Neoplasm trials